HLN
Haleon Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.28
−0.85%Forward multiples
Based on analyst estimates
- P/E forward
- 20.57x
- P/E 2026E
- 16.26x
- P/E 2027E
- 14.94x
- P/E 2028E
- 13.74x
- P/S forward
- 2.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.29x
- PEG TTM
- 2.27x
- Price / book
- 1.88x
- Price / sales
- 2.77x
- Price / cash flow
- 13.36x
Enterprise value
- Enterprise value
- $50.8B
- EV / sales
- 3.44x
- EV / EBITDA
- 13.19x
- EV / EBIT
- 15.75x
- Market cap
- $40.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026